333 related articles for article (PubMed ID: 27001617)
1. System-based proteomic and metabonomic analysis of the Df(16)A
Wesseling H; Xu B; Want EJ; Holmes E; Guest PC; Karayiorgou M; Gogos JA; Bahn S
Mol Psychiatry; 2017 Mar; 22(3):384-395. PubMed ID: 27001617
[TBL] [Abstract][Full Text] [Related]
2. Hippocampal Proteomic and Metabonomic Abnormalities in Neurotransmission, Oxidative Stress, and Apoptotic Pathways in a Chronic Phencyclidine Rat Model.
Wesseling H; Want EJ; Guest PC; Rahmoune H; Holmes E; Bahn S
J Proteome Res; 2015 Aug; 14(8):3174-87. PubMed ID: 26043028
[TBL] [Abstract][Full Text] [Related]
3. Untargeted metabolomic, and proteomic analysis identifies metabolic biomarkers and pathway alterations in individuals with 22q11.2 deletion syndrome.
Zafarullah M; Angkustsiri K; Quach A; Yeo S; Durbin-Johnson BP; Bowling H; Tassone F
Metabolomics; 2024 Feb; 20(2):31. PubMed ID: 38418685
[TBL] [Abstract][Full Text] [Related]
4. Altered expression of hippocampal dentate granule neuron genes in a mouse model of human 22q11 deletion syndrome.
Jurata LW; Gallagher P; Lemire AL; Charles V; Brockman JA; Illingworth EL; Altar CA
Schizophr Res; 2006 Dec; 88(1-3):251-9. PubMed ID: 17008057
[TBL] [Abstract][Full Text] [Related]
5. Differential gene expression in the hippocampus of the Df1/+ mice: a model for 22q11.2 deletion syndrome and schizophrenia.
Sivagnanasundaram S; Fletcher D; Hubank M; Illingworth E; Skuse D; Scambler P
Brain Res; 2007 Mar; 1139():48-59. PubMed ID: 17292336
[TBL] [Abstract][Full Text] [Related]
6. Update on the 22q11.2 deletion syndrome and its relevance to schizophrenia.
Van L; Boot E; Bassett AS
Curr Opin Psychiatry; 2017 May; 30(3):191-196. PubMed ID: 28230630
[TBL] [Abstract][Full Text] [Related]
7. Age-dependent expression pattern in the mammalian brain of a novel, small peptide encoded in the 22q11.2 deletion syndrome region.
Kragness S; Harrison MAA; Westmoreland JJ; Burstain A; Earls LR
Gene Expr Patterns; 2018 Jun; 28():95-103. PubMed ID: 29571919
[TBL] [Abstract][Full Text] [Related]
8. Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome.
Bassett AS; Marshall CR; Lionel AC; Chow EW; Scherer SW
Hum Mol Genet; 2008 Dec; 17(24):4045-53. PubMed ID: 18806272
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs as the cause of schizophrenia in 22q11.2 deletion carriers, and possible implications for idiopathic disease: a mini-review.
Forstner AJ; Degenhardt F; Schratt G; Nöthen MM
Front Mol Neurosci; 2013 Dec; 6():47. PubMed ID: 24367288
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of miR-185 is a common pathogenic event in 22q11.2 deletion syndrome-related and idiopathic schizophrenia.
Sabaie H; Gharesouran J; Asadi MR; Farhang S; Ahangar NK; Brand S; Arsang-Jang S; Dastar S; Taheri M; Rezazadeh M
Metab Brain Dis; 2022 Apr; 37(4):1175-1184. PubMed ID: 35075501
[TBL] [Abstract][Full Text] [Related]
11. Selective overexpression of Comt in prefrontal cortex rescues schizophrenia-like phenotypes in a mouse model of 22q11 deletion syndrome.
Kimoto S; Muraki K; Toritsuka M; Mugikura S; Kajiwara K; Kishimoto T; Illingworth E; Tanigaki K
Transl Psychiatry; 2012 Aug; 2(8):e146. PubMed ID: 22872161
[TBL] [Abstract][Full Text] [Related]
12. TBX1 protein interactions and microRNA-96-5p regulation controls cell proliferation during craniofacial and dental development: implications for 22q11.2 deletion syndrome.
Gao S; Moreno M; Eliason S; Cao H; Li X; Yu W; Bidlack FB; Margolis HC; Baldini A; Amendt BA
Hum Mol Genet; 2015 Apr; 24(8):2330-48. PubMed ID: 25556186
[TBL] [Abstract][Full Text] [Related]
13. A combined metabonomic and proteomic approach identifies frontal cortex changes in a chronic phencyclidine rat model in relation to human schizophrenia brain pathology.
Wesseling H; Chan MK; Tsang TM; Ernst A; Peters F; Guest PC; Holmes E; Bahn S
Neuropsychopharmacology; 2013 Nov; 38(12):2532-44. PubMed ID: 23942359
[TBL] [Abstract][Full Text] [Related]
14. Mitochondria in complex psychiatric disorders: Lessons from mouse models of 22q11.2 deletion syndrome: Hemizygous deletion of several mitochondrial genes in the 22q11.2 genomic region can lead to symptoms associated with neuropsychiatric disease.
Devaraju P; Zakharenko SS
Bioessays; 2017 Feb; 39(2):. PubMed ID: 28044359
[TBL] [Abstract][Full Text] [Related]
15. Lymphoblast transcriptome analysis in 22q11.2 deletion syndrome individuals with schizophrenia-spectrum disorder.
Michaelovsky E; Carmel M; Gothelf D; Weizman A
World J Biol Psychiatry; 2024 Apr; 25(4):242-254. PubMed ID: 38493364
[TBL] [Abstract][Full Text] [Related]
16. Neuroanatomical phenotypes in a mouse model of the 22q11.2 microdeletion.
Ellegood J; Markx S; Lerch JP; Steadman PE; Genç C; Provenzano F; Kushner SA; Henkelman RM; Karayiorgou M; Gogos JA
Mol Psychiatry; 2014 Jan; 19(1):99-107. PubMed ID: 23999526
[TBL] [Abstract][Full Text] [Related]
17. Candidate genes and the behavioral phenotype in 22q11.2 deletion syndrome.
Prasad SE; Howley S; Murphy KC
Dev Disabil Res Rev; 2008; 14(1):26-34. PubMed ID: 18636634
[TBL] [Abstract][Full Text] [Related]
18. Gene dosage in the developing and adult brain in a mouse model of 22q11 deletion syndrome.
Meechan DW; Maynard TM; Wu Y; Gopalakrishna D; Lieberman JA; LaMantia AS
Mol Cell Neurosci; 2006 Dec; 33(4):412-28. PubMed ID: 17097888
[TBL] [Abstract][Full Text] [Related]
19. Thalamic miR-338-3p mediates auditory thalamocortical disruption and its late onset in models of 22q11.2 microdeletion.
Chun S; Du F; Westmoreland JJ; Han SB; Wang YD; Eddins D; Bayazitov IT; Devaraju P; Yu J; Mellado Lagarde MM; Anderson K; Zakharenko SS
Nat Med; 2017 Jan; 23(1):39-48. PubMed ID: 27892953
[TBL] [Abstract][Full Text] [Related]
20. Targeted multiplexed selected reaction monitoring analysis evaluates protein expression changes of molecular risk factors for major psychiatric disorders.
Wesseling H; Gottschalk MG; Bahn S
Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25539505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
